STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials →

In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.